PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that Dr. John Rothman, EVP of Science & Operations at Advaxis, and Dr. Robert Petit, VP of Clinical Operations at Advaxis, will present at the World Vaccine Congress 2012 at the Gaylord National Hotel and Convention Center in Washington, DC on April 10-12, 2012.
